These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24375726)

  • 21. Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
    Nakagawa I; Wada T; Park HS; Nishimura F; Yamada S; Nakagawa H; Kichikawa K; Nakase H
    J Vasc Surg; 2014 Mar; 59(3):761-7. PubMed ID: 24239116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
    Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
    Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic treatment of DA-8159, a new phosphodiesterase type V inhibitor, attenuates endothelial dysfunction in stroke-prone spontaneously hypertensive rat.
    Choi SM; Kim JE; Kang KK
    Life Sci; 2006 Feb; 78(11):1211-6. PubMed ID: 16214180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of cilostazol against hemorrhagic stroke: Current and future perspectives.
    Takagi T; Hara H
    J Pharmacol Sci; 2016 Jul; 131(3):155-61. PubMed ID: 27381422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
    Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
    Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism.
    Biscetti F; Pecorini G; Straface G; Arena V; Stigliano E; Rutella S; Locatelli F; Angelini F; Ghirlanda G; Flex A
    Int J Cardiol; 2013 Aug; 167(3):910-6. PubMed ID: 22473072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of angiopoietin-like 4 on cerebrovascular and functional damages in ischaemic stroke.
    Bouleti C; Mathivet T; Coqueran B; Serfaty JM; Lesage M; Berland E; Ardidie-Robouant C; Kauffenstein G; Henrion D; Lapergue B; Mazighi M; Duyckaerts C; Thurston G; Valenzuela DM; Murphy AJ; Yancopoulos GD; Monnot C; Margaill I; Germain S
    Eur Heart J; 2013 Dec; 34(47):3657-68. PubMed ID: 23674618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pericyte-endothelial cell interaction increases MMP-9 secretion at the blood-brain barrier in vitro.
    Zozulya A; Weidenfeller C; Galla HJ
    Brain Res; 2008 Jan; 1189():1-11. PubMed ID: 18061148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triple antiplatelet therapy with addition of cilostazol to aspirin and clopidogrel for Y-stent-assisted coil embolization of cerebral aneurysms.
    Kono K; Shintani A; Yoshimura R; Okada H; Tanaka Y; Fujimoto T; Tomura N; Terada T
    Acta Neurochir (Wien); 2013 Aug; 155(8):1549-57. PubMed ID: 23715948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An oral administration of cilostazol before focal ischemia reduces the infarct volume with delayed cerebral blood flow increase in rats.
    Yuzawa I; Yamada M; Fujii K
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):281-6. PubMed ID: 18755408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of angiogenic and vasculogenic factors in human lymphedematous tissue.
    Couto RA; Kulungowski AM; Chawla AS; Fishman SJ; Greene AK
    Lymphat Res Biol; 2011; 9(3):143-9. PubMed ID: 22066744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice.
    Li Y; Lu Z; Keogh CL; Yu SP; Wei L
    J Cereb Blood Flow Metab; 2007 May; 27(5):1043-54. PubMed ID: 17077815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cilostazol ameliorates collagenase-induced cerebral hemorrhage by protecting the blood-brain barrier.
    Takagi T; Imai T; Mishiro K; Ishisaka M; Tsujimoto M; Ito H; Nagashima K; Matsukawa H; Tsuruma K; Shimazawa M; Yoshimura S; Kozawa O; Iwama T; Hara H
    J Cereb Blood Flow Metab; 2017 Jan; 37(1):123-139. PubMed ID: 26661252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cilostazol protects against microvascular brain injury in a rat model of type 2 diabetes.
    Tsukamoto Y; Nagata E; Fukuyama N; Itoh Y; Yuzawa H; Kohara S; Shimizu M; Takahari Y; Takizawa S
    Neurosci Res; 2017 Apr; 117():48-53. PubMed ID: 27939902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of cilostazol for secondary stroke prevention: an old dog with new tricks?
    Ansara AJ; Shiltz DL; Slavens JB
    Ann Pharmacother; 2012 Mar; 46(3):394-402. PubMed ID: 22353234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model.
    Aoki M; Morishita R; Hayashi S; Jo N; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Diabetologia; 2001 Aug; 44(8):1034-42. PubMed ID: 11484082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
    Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
    Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions.
    Yamagishi S; Yonekura H; Yamamoto Y; Fujimori H; Sakurai S; Tanaka N; Yamamoto H
    Lab Invest; 1999 Apr; 79(4):501-9. PubMed ID: 10212003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cilostazol attenuates ischemic brain injury and enhances neurogenesis in the subventricular zone of adult mice after transient focal cerebral ischemia.
    Tanaka Y; Tanaka R; Liu M; Hattori N; Urabe T
    Neuroscience; 2010 Dec; 171(4):1367-76. PubMed ID: 20933581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.